Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Operating Leases (2019 - 2026)

Select Medical Holdings (SEM) has disclosed Operating Leases for 8 consecutive years, with $931.2 million as the latest value for Q1 2026.

  • For Q1 2026, Operating Leases rose 18.19% year-over-year to $931.2 million; the TTM value through Mar 2026 reached $931.2 million, up 18.19%, while the annual FY2025 figure was $835.4 million, 13.59% down from the prior year.
  • Operating Leases hit $931.2 million in Q1 2026 for Select Medical Holdings, up from $835.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.2 billion in Q3 2024 and bottomed at $787.9 million in Q1 2025.
  • Average Operating Leases over 5 years is $954.3 million, with a median of $967.8 million recorded in 2022.
  • Year-over-year, Operating Leases fell 29.64% in 2025 and then grew 18.19% in 2026.
  • Select Medical Holdings' Operating Leases stood at $1.0 billion in 2022, then fell by 16.6% to $841.0 million in 2023, then rose by 14.95% to $966.7 million in 2024, then decreased by 13.59% to $835.4 million in 2025, then grew by 11.47% to $931.2 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $931.2 million, $835.4 million, and $818.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.